MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma

World Journal of Clinical Oncology

Volumn 5, Issue 5, 2014, Pages 1068-1077

  Chen, Xin ^a   Guo, Jia ^a   Xi, Ru Xing ^a   Chang, Yu Wei ^a   Pan, Fei Yang ^b   Zhang, Xiao Zhi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Cell cycle arrest; MiR 210; Oesophageal squamous cell carcinoma; Radiation resistance; Stem like cells

Indexed keywords

EID: 84925871531     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i5.1068     Document Type: Article

References (30)

1. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284: 33161-33168 [PMID: 19721136 DOI: 10.1074/jbc. M109.020925]
2. Yang W, Sun T, Cao J, Liu F, Tian Y, Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 2012; 318: 944-954 [PMID: 22387901 DOI: 10.1016/j.yexcr.2012.02.010]
3. Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol 2013; 34: 481-491 [PMID: 23150176 DOI: 10.1007/s13277-012-0573-2]
4. Wang F, Xiong L, Huang X, Zhao T, Wu LY, Liu ZH, Ding X, Liu S, Wu Y, Zhao Y, Wu K, Zhu LL, Fan M. miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res 2013; 11: 657-667 [PMID: 23688833 DOI: 10.1016/j.scr.2013.04.005]
5. Yang W, Wei J, Sun T, Liu F. Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice. Radiat Oncol 2013; 8: 102 [PMID: 23618526 DOI: 10.1186/1748-717X-8-102]
6. Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noël A, Pouysségur J, Barbry P, Mazure NM, Mari B. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis 2013; 4: e544 [PMID: 23492775 DOI: 10.1038/cddis.2013.71]
7. Bueno RC, Canevari RA, Villacis RA, Domingues MA, Caldeira JR, Rocha RM, Drigo SA, Rogatto SR. ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas. Ann Onco 2014: 25: 69-75 [PMID: 24285016]
8. Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W, Yuan CS. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol 2013; 43: 289-296 [PMID: 23686257 DOI: 10.3892/ijo.2013.1946]
9. Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol 2014; 8: 83-92 [PMID: 24145123 DOI: 10.1016/j.molonc.2013.09.004]
10. Winnicki K. ATM/ATR-dependent Tyr15 phosphorylation of cyclin-dependent kinases in response to hydroxyurea in Vicia faba root meristem cells. Protoplasma 2013; 250: 1139-1145 [PMID: 23468117 DOI: 10.1007/]
11. Lahm A, Uhl M, Lehr HA, Ihling C, Kreuz PC, Haberstroh J. Photoshop-based image analysis of canine articular cartilage after subchondral damage. Arch Orthop Trauma Surg 2004; 124: 431-436 [PMID: 15365719]
12. Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med 2013; 11: 10 [PMID: 23302469 DOI: 10.1186/1479-5876-11-1]
13. Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer 2010; 126: 2553-2562 [PMID: 19830692 DOI: 10.1002/ijc.24960]
14. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, Grandori C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009; 8: 2756-2768 [PMID: 19652553]
15. McCormick RI, Blick C, Ragoussis J, Schoedel J, Mole DR, Young AC, Selby PJ, Banks RE, Harris AL. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer 2013; 108: 1133-1142 [PMID: 23449350 DOI: 10.1038/bjc.2013.56]
16. Takikawa T, Masamune A, Hamada S, Nakano E, Yoshida N, Shimosegawa T. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Biochem Biophys Res Commun 2013; 437: 433-439 [PMID: 23831622 DOI: 10.1016/j.bbrc.2013.06.097]
17. Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, Voros D. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 2013; 42: 67-71 [PMID: 22850622 DOI: 10.1097/MPA.0b013e3182592ba7]
18. Liu Y, Han Y, Zhang H, Nie L, Jiang Z, Fa P, Gui Y, Cai Z. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS One 2012; 7: e52280 [PMID: 23284967 DOI: 10.1371/journal.pone.0052280]
19. Toyama T, Kondo N, Endo Y, Sugiura H, Yoshimoto N, Iwasa M, Takahashi S, Fujii Y, Yamashita H. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol 2012; 42: 256-263 [PMID: 22323552 DOI: 10.1093/jjco/hys001]
20. Hong L, Yang J, Han Y, Lu Q, Cao J, Syed L. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis. Gene 2012; 507: 135-138 [PMID: 22842193 DOI: 10.1016/j.gene.2012.07.025]
21. Võsa U, Vooder T, Kolde R, Vilo J, Metspalu A, Annilo T. Meta-analysis of microRNA expression in lung cancer. Int J Cancer 2013; 132: 2884-2893 [PMID: 23225545 DOI: 10.1002/ijc.27981]
22. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-6200 [PMID: 19789312 DOI: 10.1158/1078-0432.CCR-09-1467]
23. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y, Shimizu K, Tsujimoto G. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 2011; 286: 420-428 [PMID: 21044961 DOI: 10.1074/jbc.M110.170852]
24. Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M. Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells. J Pathol 2011; 224: 280-288 [PMID: 21465485 DOI: 10.1002/path.2860]
25. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros D, Weber BL, Simon C, Coukos G, Zhang L. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 2008; 7: 255-264 [PMID: 18059191]
26. Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010; 9: 1072-1083 [PMID: 20237418]
27. Hu YC, Hsieh BS, Cheng HL, Huang LW, Huang TC, Huang IY, Chang KL. Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway. Biochem Pharmacol 2013; 85: 1018-1026 [PMID: 23337567 DOI: 10.1016/j.bcp.2013.01.008]
28. Martín M, Terradas M, Tusell L, Genescà A. ATM and DNAPKcs make a complementary couple in DNA double strand break repair. Mutat Res 2012; Epub ahead of print [PMID: 22230547]
29. Yan D, Ng WL, Zhang X, Domingues MA, Caldeira JR, Rocha RM, Drigo SA, Rogatto SR. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010; 5: e11397 [DOI: 10.1371/journal.pone.0011397]
30. Lindenbergh-van der Plas M, Martens-de Kemp SR, de Maaker M, van Wieringen WN, Ylstra B, Agami R, Cerisoli F, Leemans CR, Braakhuis BJ, Brakenhoff RH. Identification of lethal microRNAs specific for head and neck cancer. Clin Cancer Res 2013; 19: 5647-5657 [PMID: 23942092 DOI: 10.1158/1078-0432.CCR-12-2295]